Held by 64 funds across 13 fund houses in our coverage.
Coverage: 22 of India's largest fund houses — growing.
As of the latest monthly AMC disclosures, Cohance Lifesciences is held by 64 mutual funds and ETFs in our database. The total value of equity held across these schemes is ₹2,128 Cr. Among all holding funds, the manager with the highest conviction is ICICI Prudential Pharma Healthcare and Diagnostics Fund (ICICI Pru MF), which allocates a significant 4.37% of its entire portfolio to Cohance Lifesciences.
In terms of category distribution, Sectoral / Thematic funds hold the largest exposure by market value, representing 11 positions. Across different fund houses, DSP MF manages the largest aggregate stake, holding a combined value of ₹707 Cr. This distribution indicates whether the stock is favored by active diversified equity managers or is primarily held in sector-specific/thematic portfolios.
Portfolios as on: ICICI Pru MF May 2026 · DSP MF May 2026 · UTI MF May 2026 · SBI MF May 2026 · Motilal Oswal MF Apr 2026 · Tata MF May 2026 · Aditya Birla SL MF Apr 2026 · Kotak MF May 2026 · Groww MF Oct 2025 · Nippon India MF Apr 2024 · HDFC MF May 2026 · ITI MF May 2026 · Axis MF May 2026. ISIN-verified equity positions from public AMC disclosures. Not investment advice.
Weight = the position as a % of that fund's portfolio. MoM = change vs the previous month's disclosure. Values in ₹: L = Lakh (1,00,000), Cr = Crore (1,00,00,000).